1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > MEDITE Cancer Diagnostics, Inc. (MDIT) - Product Pipeline Analysis, 2016 Update

MEDITE Cancer Diagnostics, Inc. (MDIT) - Product Pipeline Analysis, 2016 Update

  • June 2016
  • -
  • GlobalData
  • -
  • 39 pages

Summary

Table of Contents

Search Inside

Summary

MEDITE Cancer Diagnostics, Inc. (MEDITE), formerly CytoCore, Inc., specializes in the development, engineering, manufacturing and marketing of premium medical devices and consumables for detection, risk assessment and diagnosis of cancer and related diseases. Its major devices include ultrasonic decalcification instruments, tissue processing instruments, freezing microtome, cryostats, linear staining systems, staining systems, robotic coverslippers, and cytology screening systems. The company products find application in processing tissue, cell collection ranging from processing to diagnosis. These devices and consumables are manufactured at is facility in Burgdorf, Germany. The company sells its products through a direct sale force located in Germany, Poland and the US, and also through independent distributors. The company is headquartered in Orlando, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company MEDITE Cancer Diagnostics, Inc.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Colon Cancer - Pipeline Review, H2 2016

Colon Cancer - Pipeline Review, H2 2016

  • $ 2500
  • Company report
  • December 2016
  • by Global Markets Direct

Colon Cancer - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Colon Cancer – Pipeline Review, H2 2016, provides an overview of ...

Liver Cancer - Pipeline Review, H2 2016

Liver Cancer - Pipeline Review, H2 2016

  • $ 2500
  • Company report
  • December 2016
  • by Global Markets Direct

Liver Cancer - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Liver Cancer – Pipeline Review, H2 2016, provides an overview of ...

Wilms’ Tumor (Nephroblastoma) - Pipeline Review, H2 2016

Wilms’ Tumor (Nephroblastoma) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • December 2016
  • by Global Markets Direct

Wilms’ Tumor (Nephroblastoma) - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Wilms’ Tumor (Nephroblastoma) – Pipeline Review, ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.